Ortega-Robles Emmanuel, Carino-Escobar Ruben I, Cantillo-Negrete Jessica, Arias-Carrión Oscar
División de Investigación en Neurociencias Clínica, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City 14389, Mexico.
Subdirección de Investigación Tecnológica, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City 14389, Mexico.
Biomimetics (Basel). 2025 Jul 23;10(8):488. doi: 10.3390/biomimetics10080488.
Parkinson's disease (PD) is a progressive neurological disorder with motor and non-motor symptoms that are inadequately addressed by current pharmacological and surgical therapies. Brain-computer interfaces (BCIs), particularly those based on electroencephalography (eBCIs), provide a promising, non-invasive approach to personalized neurorehabilitation. This narrative review explores the clinical potential of BCIs in PD, discussing signal acquisition, processing, and control paradigms. eBCIs are well-suited for PD due to their portability, safety, and real-time feedback capabilities. Emerging neurophysiological biomarkers-such as beta-band synchrony, phase-amplitude coupling, and altered alpha-band activity-may support adaptive therapies, including adaptive deep brain stimulation (aDBS), as well as motor and cognitive interventions. BCIs may also aid in diagnosis and personalized treatment by detecting these cortical and subcortical patterns associated with motor and cognitive dysfunction in PD. A structured search identified 11 studies involving 64 patients with PD who used BCIs for aDBS, neurofeedback, and cognitive rehabilitation, showing improvements in motor function, cognition, and engagement. Clinical translation requires attention to electrode design and user-centered interfaces. Ethical issues, including data privacy and equitable access, remain critical challenges. As wearable technologies and artificial intelligence evolve, BCIs could shift PD care from intermittent interventions to continuous, brain-responsive therapy, potentially improving patients' quality of life and autonomy. This review highlights BCIs as a transformative tool in PD management, although more robust clinical evidence is needed.
帕金森病(PD)是一种进行性神经疾病,具有运动和非运动症状,目前的药物和手术治疗对这些症状的处理并不充分。脑机接口(BCI),特别是基于脑电图的脑机接口(eBCI),为个性化神经康复提供了一种有前景的非侵入性方法。本叙述性综述探讨了BCI在帕金森病中的临床潜力,讨论了信号采集、处理和控制范式。由于其便携性、安全性和实时反馈能力,eBCI非常适合帕金森病。新兴的神经生理学生物标志物,如β波段同步、相位-幅度耦合和改变的α波段活动,可能支持适应性治疗,包括适应性深部脑刺激(aDBS)以及运动和认知干预。BCI还可以通过检测与帕金森病运动和认知功能障碍相关的这些皮质和皮质下模式,辅助诊断和个性化治疗。一项结构化搜索确定了11项研究,涉及64名使用BCI进行aDBS、神经反馈和认知康复的帕金森病患者,结果显示运动功能、认知和参与度有所改善。临床转化需要关注电极设计和以用户为中心的界面。伦理问题,包括数据隐私和公平获取,仍然是关键挑战。随着可穿戴技术和人工智能的发展,BCI可能会将帕金森病护理从间歇性干预转变为持续的、对大脑有反应的治疗,有可能提高患者的生活质量和自主性。本综述强调BCI是帕金森病管理中的一种变革性工具,尽管还需要更有力的临床证据。